{
    "Case ID": "047751",
    "Crime_Name": [
        "Patent Infringement Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Infringement Dispute"
    ],
    "Legal_Issue": [
        "Whether Apotex must disclose portions of its drug submission process for paroxetine hydrochloride to assess non-infringement claims"
    ],
    "Governing_Law": [
        "Section 6(7) of the Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Procedural_Stage": [
        "Motion"
    ],
    "Evidence_Assessment": [
        "SmithKline provided expert evidence; Apotex argued process details were irrelevant"
    ],
    "Decision_Outcome": [
        "Disclosure necessary for assessing infringement"
    ],
    "Burden_of_Proof": [
        "On Apotex to demonstrate that disclosure is unnecessary or irrelevant"
    ],
    "Credibility_Factor": [
        "Expert evidence presented by SmithKline"
    ],
    "Legal_Rule": [
        "Courts may order production of relevant portions of a drug submission and verification by the Minister under Section 6(7)"
    ],
    "Standard_of_Review": [
        "Relevance and necessity of disclosed information for assessing infringement"
    ],
    "Procedural_Issue": [
        "Motion for disclosure and verification orders"
    ],
    "Grounds_for_Claim": [
        "Alleged patent infringement and inadequate disclosure under regulatory requirements"
    ],
    "Outcome_on_Merits": [
        "Court found disclosure necessary"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Motion granted"
    ],
    "Review_Standard": [
        "Assessment of relevance and compliance with regulatory obligations"
    ],
    "Procedural_Fairness_Assessment": [
        "Balancing need for transparency with proprietary concerns in drug submissions"
    ],
    "Key_Evidence_Considered": [
        "Expert evidence on manufacturing process, submission documents"
    ],
    "Legal_Framework": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Applicant_Challenge": [
        "SmithKline challenged adequacy of Apotex's disclosure"
    ],
    "Court_Result": [
        "Apotex must produce relevant portions of its submission; Minister must verify correspondence with filed information"
    ],
    "Legal_Rule_Source": [
        "Section 6(7) of the Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Apotex contended that process details were irrelevant to the infringement analysis"
    ],
    "Evidence_Type": [
        "Documentary evidence, expert testimony"
    ],
    "Remedy_Requested": [
        "Disclosure and verification orders"
    ],
    "Outcome": [
        "Motion granted; disclosure and verification required"
    ],
    "Decision_Authority": [
        "Court"
    ],
    "Remedy_Sought": [
        "Order for production and ministerial verification"
    ],
    "Resolution_Mechanism": [
        "Judicial determination on motion"
    ],
    "Legal_Provision": [
        "Section 6(7) of the Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Authority": [
        "Canadian court"
    ],
    "Claimant_Status": [
        "SmithKline as patent holder"
    ],
    "Legal_Provision_Cited": [
        "Section 6(7) of the Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Insufficient disclosure by Apotex regarding drug submission process"
    ],
    "Applicable_Process": [
        "Regulatory and judicial process under NOC Regulations"
    ],
    "Outcome_of_Review": [
        "Disclosure ordered"
    ],
    "Pending_Relief_or_Application": [
        "Disclosure and verification orders"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Section 6(7) of the Patented Medicines (Notice of Compliance) Regulations"
    ]
}